Dr Lisa Page
Dr Lisa Page is an Intellectual Property lawyer who leads the Shoosmiths LLP pharmaceutical and life sciences practice. A PhD in molecular microbiology coupled with direct practical experience of working in the pharmaceutical industry makes her unique as she truly understands the science that underpins issues faced by clients in the Life Sciences’ sector. Project management and in-house legal roles, including at a University in-house legal team where she was responsible for research across the University and its commercial entities, mean that her advice is tailored and always pragmatic.
Lisa’s practical experience includes drug development, registration, regulatory, pharmacovigilance, pre-clinical and clinical development, collaborations and spin-outs. This deep understanding of the development stage of new products, the pipeline, co-development, out-licensing and in-licensing arrangements is a critical factor for clients. She can speak clients’ language when providing specialist advice in relation to development programmes and exploitation of Life Science technologies.
Alongside Life Sciences IP, Lisa has a separate practice advising on State aid issues. This developed at the Energy Technologies Institute and continued with University work and in private practice. The advice is focussed on State aid as it applies to research and development including the R&D&I Framework and GBER. She has advised on a number of high value grant funded projects, research infrastructure projects as well as advising research organisations more generally on State aid compliance.
Enjoyed what you heard in the session but want to find out more? This is your chance to ask questions in a much smaller group, and delve into the topics in more detail.
|Speakers:||David Sweeney, Prof Emma Flynn, Vivienne Stern, Dr Lisa Page|